Taro-zoledronic Acid (2020-03-30)
Taro-Zoledronic Acid Recall Summary Taro Pharmaceuticals is recalling Zoledronic Acid across Canada due to product safety concerns. Zoledronic Acid is a medication used to treat bone conditions like osteoporosis and certain cancers. This Class I recall affects all patients who have received or are using this drug in Canada.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2020-03-30
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/94792618-59eb-41f0-beab-1ebb2ecb9d10